UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 16, 2004
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
| 1-15525 |
| 36-4316614 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
|
|
|
|
|
One Edwards Way, Irvine, California |
|
|
| 92614 |
(Address of principal executive offices) |
|
|
| (Zip Code) |
|
|
|
|
|
(949) 250-2500 | ||||
Registrant’s telephone number, including area code | ||||
Item 5. Other Events.
On January 16, 2004, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced the conclusion of a dispute resolution proceeding with Baxter International Inc. ("Baxter") regarding certain disagreements between the two companies arising from the Company’s spin-off from Baxter in April 2000. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 7. Financial Statements and Exhibits.
(c) Exhibits:
99.1 Press release dated January 16, 2004
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 16, 2004 |
| ||
|
| ||
|
| ||
| EDWARDS LIFESCIENCES CORPORATION | ||
|
| ||
|
| ||
| By: | /s/ Corinne H. Lyle |
|
|
| Corinne H. Lyle | |
|
| Corporate Vice President, | |
3
EXHIBIT INDEX
The following exhibit is filed herewith:
Exhibit No. |
| Description |
|
|
|
99.1 |
| Press release dated January 16, 2004 |
4
